Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Canna-V-Cell Sciences (CNVCF)

Canna-V-Cell Sciences (CNVCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioHarvest Sciences Reports First Quarter 2024 Financial Results

Q1 2024 Revenue Increased 147% Year-over-Year to US$5.34 Million Exceeding Previous Guidance Management Expects Q2 2024 Revenue in the Range of US$5.7-6.0 MillionVancouver, British Columbia and Rehovot,...

CNVCF : 0.1867 (+3.72%)
BHSC.CN : 8.2500 (-1.79%)
BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 1, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering...

CNVCF : 0.1867 (+3.72%)
BHSC.CN : 8.2500 (-1.79%)
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

FY 2023 Revenue Increased 2.3x to $12.7 Million USDThe Company expects Q1 2024 Revenue to be in the range of $5.2 million to $5.3 million and is providing Q2 2024 Revenue Guidance of $5.7-$6.0 millionManagement...

CNVCF : 0.1867 (+3.72%)
BHSC.CN : 8.2500 (-1.79%)
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity

80,000 Square Foot (7,500 Square Meter) Property includes 12 GMP Clean Rooms, Laboratory and Office space, and can accommodate expanded 50 Ton Manufacturing facility New Production Technologies Implemented...

CNVCF : 0.1867 (+3.72%)
BHSC.CN : 8.2500 (-1.79%)
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables

Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business UnitVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 21, 2024) - BioHarvest...

CNVCF : 0.1867 (+3.72%)
BHSC.CN : 8.2500 (-1.79%)
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 14, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering...

CNVCF : 0.1867 (+3.72%)
BHSC.CN : 8.2500 (-1.79%)
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit

Management Adding Critical Leadership Roles to Support Growth of Recently Launched CDMO Business UnitVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 13, 2024) - BioHarvest Sciences...

CNVCF : 0.1867 (+3.72%)
BHSC.CN : 8.2500 (-1.79%)
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering...

CNVCF : 0.1867 (+3.72%)
BHSC.CN : 8.2500 (-1.79%)
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering...

CNVCF : 0.1867 (+3.72%)
BHSC.CN : 8.2500 (-1.79%)
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 26, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a biotechnology...

CNVCF : 0.1867 (+3.72%)
BHSC.CN : 8.2500 (-1.79%)

Barchart Exclusives

Unusual Options Activity Supports Rivian (RIVN) But Infrastructure is Key
Although RIVN stock is riding high on a major investment deal, the real beneficiary could be the EV infrastructure play. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar